Overview

Study to Evaluate the Efficacy and Safety of Combination Aliskiren/Amlodipine in Patients Not Adequately Responding to Aliskiren Alone

Status:
Completed
Trial end date:
2009-05-01
Target enrollment:
Participant gender:
Summary
This study will assess the safety and efficacy of combination aliskiren/amlodipine in patients not adequately controlled with aliskiren alone
Phase:
Phase 3
Details
Lead Sponsor:
Novartis
Treatments:
Amlodipine